|
| Iron isomaltoside | Oral iron | ||
|
| AEs, n (%) | SAEs, n %) | AEs, n (%) | SAEs, n %) |
| Rash | 5 (5.1%) | - | - | - |
| Arthralgia | 2 (2.0%) | - | - | - |
| Hyperpigmentation of the skin | 2 (2.0%) | - | - | - |
| Dyspnea | 1 (1.0%) | - | - | - |
| Anaphylaxis | 1 (1.0%) | 1 (1.0%) | - | - |
| Constipation | - | - | 7 (5.4%) | - |
| Abdominal pain | - | - | 5 (3.9%) | - |
| Nausea | - | - | 5 (3.9%) | - |
| Diarrhea | - | - | 3 (2.3%) | - |